Clinical Trials Directory

Trials / Conditions / Human Papillomavirus Infection

Human Papillomavirus Infection

116 registered clinical trials studyying Human Papillomavirus Infection14 currently recruiting.

StatusTrialSponsorPhase
WithdrawnIncidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive M
NCT04142398
AIDS Malignancy Consortium
Not Yet RecruitingEffect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women
NCT07521163
Muhammet Faruk YigitN/A
RecruitingPoint of Care - Triage and Treatment for Cervical Pre-cancer
NCT07461818
Basic Health International, Inc.N/A
RecruitingSelf-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
NCT07281430
National Cancer Institute (NCI)N/A
Enrolling By InvitationOffering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening
NCT07186530
Mayo ClinicN/A
Not Yet RecruitingTransmission of Oncogenic HPV Infection Among Families
NCT07036211
Tampere University Hospital
WithdrawnSaliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
NCT06362421
Wake Forest University Health Sciences
Not Yet RecruitingThe Effect of Health Belief Model-Based Education and Motivational Interviewing on HPV (Human Papilloma Virus)
NCT07097766
Saglik Bilimleri UniversitesiN/A
RecruitingInvestigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers
NCT06598475
The University of Texas Health Science Center, HoustonN/A
Not Yet RecruitingClinical Study to Evaluate SIIPL QHPV Vaccine (CERVAVAC®) in Women Living with HIV Aged 15-25 Years
NCT06281119
Serum Institute of India Pvt. Ltd.Phase 3
Active Not RecruitingSelf-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
NCT06611553
National Cancer Institute (NCI)N/A
Active Not RecruitingSelf-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)
NCT06611540
National Cancer Institute (NCI)N/A
Not Yet RecruitingCervical Cytology DNA Methylation for Cervical Cancer Screening
NCT06557954
Lei Li
UnknownComparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection
NCT06213051
Foundation for Innovative New Diagnostics, Switzerland
RecruitingSelf-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
NCT06498661
National Cancer Institute (NCI)N/A
CompletedThe Role of Cyberchondria Severity in the Relationship Between HPV Awareness and Vaccination Attitudes in Adul
NCT06800456
Acibadem University
Active Not RecruitingEvaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
NCT06491446
Antiva BiosciencesPhase 1 / Phase 2
UnknownProbiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papi
NCT06245486
Liaquat University of Medical & Health SciencesN/A
RecruitingNormalizing Antibody Detection in First-void Urine
NCT06582654
Universiteit Antwerpen
UnknownA Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine
NCT06207175
Beijing Health Guard Biotechnology, IncPhase 3
UnknownHPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population
NCT05981807
ANRS, Emerging Infectious Diseases
Active Not RecruitingProspective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
NCT06577220
Baylor College of MedicineN/A
UnknownPhase I Clinical Trial of a Candidate HPV Vaccine
NCT05672966
Wuhan BravoVax Co., Ltd.Phase 1
Active Not RecruitingImplementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary
NCT06256718
Roswell Park Cancer InstituteN/A
Active Not RecruitingLong-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
NCT06776055
Shanghai Zerun Biotechnology Co.,Ltd
RecruitingFeasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesita
NCT05860725
University of VirginiaN/A
UnknownHuman Papillomavirus in Young People Epidemiological Research 3
NCT05587725
Monash University
UnknownHuman Papillomavirus in Young People Epidemiological Research 4
NCT05587738
Monash University
Active Not RecruitingPrimary Cervical Cancer Screening by Self-sampling HPV Test
NCT05613283
Peking University People's Hospital
CompletedEfficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive Patients
NCT06199128
Uriach Consumer Healthcare
CompletedEvaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trau
NCT05458869
OHSU Knight Cancer Institute
RecruitingRole of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
NCT05774561
The Institute of Molecular and Translational Medicine, Czech Republic
Active Not RecruitingA Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Year
NCT05662020
Beijing Health Guard Biotechnology, IncPhase 3
UnknownCervical Cancer Screening Strategies
NCT05309122
Lei Li
CompletedEfficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infect
NCT06802809
Liaquat University of Medical & Health SciencesN/A
CompletedSerum Galectin-3 as a Marker of Human Papillomavirus Infection
NCT06005389
Assiut University
UnknownClinical Evaluation of Detection of High Risk HPV in Urine
NCT05210348
Peking University People's Hospital
CompletedMultilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalach
NCT04411849
Ohio State University Comprehensive Cancer CenterN/A
Active Not RecruitingPromoting HPV Vaccination Among Young Adults in Texas
NCT05057312
M.D. Anderson Cancer CenterN/A
CompletedScreening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV
NCT04587050
Imperial College London
CompletedCommunication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study
NCT04660331
Fred Hutchinson Cancer CenterN/A
UnknownA Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine
NCT05668572
Beijing Health Guard Biotechnology, IncPhase 3
CompletedHPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved A
NCT04474821
Mayo ClinicPhase 4
CompletedHPV Typing Between Self- and Physician-sampled
NCT04472377
Hygeia Touch Inc.N/A
CompletedProspective Evaluation of Self-Testing to Increase Screening
NCT03898167
Baylor College of MedicineN/A
CompletedImpact of HPV Vaccination on Cervical High Grade Lesions in France
NCT04167501
Centre Hospitalier Universitaire de Besancon
WithdrawnQuality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Del
NCT03887793
University of North Carolina, Chapel HillN/A
RecruitingSelf-sampling for Non-attenders to Cervical Cancer Screening
NCT04226313
The Institute of Molecular and Translational Medicine, Czech RepublicN/A
CompletedA Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
NCT05680454
Beijing Health Guard Biotechnology, IncPhase 1
UnknownA Cohort Study for the Following up of Conization
NCT03961178
Lei Li
UnknownAcceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study
NCT03813576
National University Hospital, SingaporeN/A
CompletedHPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovagina
NCT04133610
The Institute of Molecular and Translational Medicine, Czech RepublicN/A
CompletedVideo-Assisted Counseling for HPV Vaccination
NCT03510091
Le Bonheur Children's HospitalN/A
CompletedIntegrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention
NCT03346915
Boston Medical CenterN/A
Active Not RecruitingExtended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccin
NCT03309033
National Cancer Institute (NCI)
TerminatedBGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
NCT02706691
University of ChicagoPhase 2
CompletedQuality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination
NCT03442062
University of North Carolina, Chapel HillN/A
UnknownComparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
NCT03726151
University of California, Los AngelesN/A
CompletedThe Human Papilloma Virus Effect on Sexual Life
NCT03837028
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Active Not RecruitingComparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infe
NCT03180034
National Cancer Institute (NCI)Phase 4
CompletedResearch in Ethno-Medicine and Education (REMED)
NCT05907187
University of MiamiN/A
CompletedFeasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana
NCT03345875
JhpiegoN/A
UnknownA Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepi
NCT03302858
Stephen E. GoldstonePhase 2
CompletedHPV Vaccination in Women With Cystic Fibrosis
NCT03265743
Hospices Civils de Lyon
CompletedImmunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult
NCT03158220
Merck Sharp & Dohme LLCPhase 3
Active Not RecruitingPreventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
NCT03036930
National Cancer Institute (NCI)Phase 2
Active Not RecruitingThroat and Other HPV-Related Cancers in Men: Identifying Them Early
NCT02897427
Baylor College of Medicine
CompletedHuman Papillomavirus in Young People Epidemiological Research 2 (HYPER2)
NCT03000933
The Alfred
CompletedAnal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV
NCT03032575
Thai Red Cross AIDS Research CentreN/A
TerminatedDurvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
NCT02827838
Wake Forest University Health SciencesEARLY_Phase 1
CompletedA Comparison of Cotton and Flocked Swabs for Vaginal Self Collection
NCT02785289
University Hospital, GenevaN/A
WithdrawnCarrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
NCT02382419
Rutgers, The State University of New JerseyPhase 2
TerminatedLubricant Investigation in Men to Inhibit Transmission of HPV Infection
NCT02354144
McGill UniversityPhase 2 / Phase 3
Active Not RecruitingLong-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
NCT02653118
Merck Sharp & Dohme LLC
CompletedHPV Self-Test Intervention in Ohio Appalachia
NCT02460237
Ohio State University Comprehensive Cancer CenterN/A
CompletedLong Term Follow-up of HPV Vaccine in HIV (CTN 236)
NCT06915779
University of British Columbia
CompletedColposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology
NCT04369339
Bezmialem Vakif UniversityN/A
CompletedCATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community He
NCT02355262
OHSU Knight Cancer Institute
CompletedThe Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
NCT02188004
Jun Zhang
CompletedTransmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
NCT01824537
McGill UniversityPhase 4
CompletedA Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered
NCT01984697
Merck Sharp & Dohme LLCPhase 3
CompletedRadiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
NCT01932697
Mayo ClinicPhase 2
Active Not RecruitingAnal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
NCT02816879
Jonsson Comprehensive Cancer CenterN/A
WithdrawnPost-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka
NCT01551537
GlaxoSmithKline
CompletedHPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine C
NCT04333212
Chang Gung Memorial HospitalN/A
CompletedIpilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer
NCT01693783
National Cancer Institute (NCI)Phase 2
CompletedClinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System
NCT01694875
Gen-Probe, Incorporated
CompletedHome-Based or Clinic-Based Human Papillomavirus (HPV) Screening
NCT01550783
University of WashingtonN/A
CompletedSafety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
NCT01532102
Anaconda PharmaPhase 1 / Phase 2
CompletedSelf-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01588301
University Hospital, ToursEARLY_Phase 1
CompletedAn Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Amo
NCT02464358
University of ConnecticutN/A
CompletedAPTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results
NCT01384370
Gen-Probe, Incorporated
UnknownRandomized Comparison of Vaginal Self Sampling for Human Papillomavirus (HPV) Testing by Standard Versus Dry V
NCT01316120
University Hospital, GenevaN/A
CompletedAn Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt
NCT01158209
GlaxoSmithKline
CompletedAn Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain
NCT01205412
GlaxoSmithKline
TerminatedEfficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination
NCT01082861
National Institute for Public Health and the Environment (RIVM)Phase 4
CompletedPrevalence of Human Papillomavirus in Men Living in the Northern Plains
NCT01265212
Sanford Health
UnknownBrief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers
NCT01087164
Indiana UniversityN/A
UnknownRandomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)
NCT01095198
McMaster UniversityPhase 2 / Phase 3
CompletedPrevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV)
NCT01702337
GlaxoSmithKline
CompletedA Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)
NCT00988884
Merck Sharp & Dohme LLCPhase 3
CompletedAcceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers
NCT00925288
Johns Hopkins Bloomberg School of Public HealthPhase 4
CompletedStudy of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts
NCT05156541
SPP Pharmaclon Ltd.Phase 3
Active Not RecruitingCA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical C
NCT00892866
GOG FoundationN/A
Active Not RecruitingExtended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18
NCT00867464
National Cancer Institute (NCI)
CompletedPrevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men
NCT00932009
Danish Cancer Society
CompletedClinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
NCT00973362
Gen-Probe, IncorporatedPhase 3
CompletedBroad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
NCT00520598
Merck Sharp & Dohme LLCPhase 2
CompletedA Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001
NCT00551187
Merck Sharp & Dohme LLCPhase 2
CompletedBroad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
NCT00543543
Merck Sharp & Dohme LLCPhase 3
CompletedRandomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University
NCT00572832
University of PittsburghN/A
CompletedA Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents
NCT00518180
Novartis VaccinesPhase 3
CompletedObservational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose
NCT01078220
Merck Sharp & Dohme LLC
CompletedThe Human Papillomavirus (HPV) Transmission Pilot Study
NCT00823511
H. Lee Moffitt Cancer Center and Research Institute
CompletedSexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
NCT00508170
M.D. Anderson Cancer Center
CompletedUse of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysp
NCT00931190
Lund University